中华皮肤科杂志 ›› 2026, e20240720.doi: 10.35541/cjd.20240720

• 研究报道 • 上一篇    下一篇

肢体淋巴水肿伴皮肤恶性肿瘤16例临床分析

朱研,夏松,孙宇光,信建峰,沈文彬   

  1. 首都医科大学附属北京世纪坛医院淋巴外科,北京  100038
  • 收稿日期:2024-12-27 修回日期:2026-04-01 发布日期:2026-05-27
  • 通讯作者: 沈文彬 E-mail:shenwb@bjsjth.cn
  • 基金资助:
    北京市属医院科研培育计划项目(PX2022028)

Analysis of 16 cases of limb lymphedema complicated with skin malignant tumors

Zhu Yan, Xia Song, Sun Yuguang, Xin Jianfeng, Shen Wenbin   

  1. Department of Lymphatic Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China
  • Received:2024-12-27 Revised:2026-04-01 Published:2026-05-27
  • Contact: Shen Wenbin E-mail:shenwb@bjsjth.cn
  • Supported by:
    Beijing Municipal Hospital Research and Cultivation Program(PX2022028)

摘要: 【摘要】 目的 探讨肢体淋巴水肿伴皮肤恶性肿瘤患者的临床特点。方法 本研究为病例系列研究。选择首都医科大学附属北京世纪坛医院淋巴外科2017年3月至2023年3月收治的16例肢体淋巴水肿伴皮肤恶性肿瘤患者,分析肢体淋巴水肿伴皮肤恶性肿瘤患者的临床特征。结果 16例患者男3例,女13例,年龄39~79岁[(64.1 ± 9.6)岁],主要临床表现为淋巴水肿的肢体出现可触及的单发或多发的皮肤/皮下结节,其中7例皮肤肿物疼痛。16例患者行皮肤肿物切除活检或超声引导下穿刺活检,病理示10例血管肉瘤,1例鳞状细胞癌,2例乳腺癌皮肤转移,3例胃印戒细胞癌皮肤转移。11例肢体淋巴水肿继发皮肤恶性肿瘤患者中,5例行截肢手术治疗,1例化疗,1例口服靶向药物治疗,其余4例姑息治疗;5例皮肤转移癌患者中,3例接受化疗,1例化疗 + 免疫治疗,1例口服中药治疗。随访至2024年6月,11例肢体淋巴水肿继发皮肤恶性肿瘤患者中,4例无进展生存,1例肿瘤进展存活,6例死亡;5例皮肤转移癌患者中,1例无进展生存,4例死亡。结论 肢体淋巴水肿伴皮肤恶性肿瘤临床罕见,预后不良;对淋巴水肿肢体上新发皮肤恶性肿瘤患者,截肢手术或可改善预后;对淋巴水肿伴皮肤转移癌患者,化疗可能是首选治疗方法。

关键词: 淋巴水肿, 皮肤肿物, 血管肉瘤, 印戒细胞癌, 乳腺癌, 治疗, 预后

Abstract: 【Abstract】 Objective To investigate the clinical characteristics of patients with limb lymphedema complicated with skin malignant tumors. Methods It was a case series study. A total of 16 patients with limb lymphedema complicated with skin malignant tumors who were admitted to the Department of Lymphatic Surgery, Beijing Shijitan Hospital, Capital Medical University, from March 2017 to March 2023 were selected, and their clinical characteristics were analyzed. Results Among the 16 patients, there were 3 males and 13 females, aged 64.1 ± 9.6 (39 - 79) years. The main clinical manifestation was the presence of palpable solitary or multiple cutaneous/subcutaneous nodules in lymphedematous limbs, among which 7 patients experienced pain in the skin lesions. All 16 patients underwent excisional biopsy of skin lesions or ultrasound-guided needle biopsy. Pathological examination showed 10 cases of angiosarcoma, 1 case of squamous cell carcinoma, 2 cases of cutaneous metastases from breast cancer, and 3 cases of cutaneous metastases from gastric signet ring cell carcinoma. Among the 11 patients with limb lymphedema secondary to skin malignant tumors, 5 underwent amputation, 1 received chemotherapy, 1 received oral targeted therapy, and the remaining 4 received palliative treatment. Among the 5 patients with cutaneous metastatic carcinoma, 3 received chemotherapy, 1 received chemotherapy combined with immunotherapy, and 1 received oral traditional Chinese medicine treatment. Follow-up was conducted until June 2024. Among the 11 patients with limb lymphedema secondary to skin malignant tumors, 4 achieved progression-free survival, 1 survived with tumor progression, and 6 died. Among the 5 patients with cutaneous metastatic carcinoma, 1 achieved progression-free survival, and 4 died. Conclusions Limb lymphedema complicated with skin malignant tumors is clinically rare and is associated with a poor prognosis. For patients with newly developed skin malignant tumors in lymphedematous limbs, amputation may improve prognosis. For patients with lymphedema complicated with cutaneous metastatic carcinoma, chemotherapy may be the preferred treatment option.

Key words: Lymphedema, Skin mass, Angiosarcoma, Signet ring cell carcinoma, Breast cancer, Therapy, Prognosis

引用本文

朱研 夏松 孙宇光 信建峰 沈文彬. 肢体淋巴水肿伴皮肤恶性肿瘤16例临床分析[J]. 中华皮肤科杂志, 2026,e20240720. doi:10.35541/cjd.20240720

Zhu Yan, Xia Song, Sun Yuguang, Xin Jianfeng, Shen Wenbin. Analysis of 16 cases of limb lymphedema complicated with skin malignant tumors[J]. Chinese Journal of Dermatology,2026,e20240720. doi:10.35541/cjd.20240720